Thomas J. Riga
Net Worth

Last updated:

What is Thomas J. Riga net worth?

The estimated net worth of Mr. Thomas J. Riga is at least $7,710,734 as of 15 Mar 2023. He has earned $500,734 from insider trading and has received compensation worth at least $7,210,000 in Spectrum Pharmaceuticals, Inc..

What is the salary of Thomas J. Riga?

Mr. Thomas J. Riga salary is $1,030,000 per year as Pres, Chief Executive Officer & Director in Spectrum Pharmaceuticals, Inc..

How old is Thomas J. Riga?

Mr. Thomas J. Riga is 50 years old, born in 1975.

What stocks does Thomas J. Riga currently own?

As insider, Mr. Thomas J. Riga owns shares in one company:

Company Title Shares Price per share Total value
Spectrum Pharmaceuticals, Inc. (SPPI) Pres, Chief Executive Officer & Director 472,411 $0 $0

What does Spectrum Pharmaceuticals, Inc. do?

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNa, an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for the treatment of patients with relapsed or refractory non-Hodgkin's lymphoma, including diffuse large B-cell lymphoma. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. Anderson Cancer Center; and in-license agreement with ImmunGene, Inc. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was incorporated in 1987 and is based in Boston, Massachusetts.

SPPI logo
SPPI
Spectrum Pharmaceuticals, Inc.

Thomas J. Riga insider trading

Spectrum Pharmaceuticals, Inc.

Mr. Thomas J. Riga has made 38 insider trades between 2018-2023, according to the Form 4 filled with the SEC. Most recently he sold 31,381 units of SPPI stock worth $24,979 on 15 Mar 2023.

The largest trade he's ever made was exercising 107,424 units of SPPI stock on 31 Jan 2023. As of 15 Mar 2023 he still owns at least 472,411 units of SPPI stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock, $0.001 par value 31,381 $0.8 $24,979
Sale
Common Stock, $0.001 par value 18,153 $0.82 $14,867
Sale
Common Stock, $0.001 par value 14,607 $0.76 $11,116
Sale
Common Stock, $0.001 par value 22,402 $0.77 $17,250
Sale
Common Stock, $0.001 par value 107,424 $0.66 $70,900
Sale
Common Stock, $0.001 par value 69,389 $0.54 $37,748
Sale
Common Stock, $0.001 par value 23,929 $0.38 $9,141
Sale
Common Stock, $0.001 par value 18,829 $0.71 $13,293
Sale
Common Stock, $0.001 par value 20,356 $0.71 $14,351
Sale
Common Stock, $0.001 par value 18,441 $0.64 $11,802
Sale
Common Stock, $0.001 par value 19,953 $0.7 $14,027
Sale
Common Stock, $0.001 par value 2,250 N/A N/A
Sale
Common Stock, $0.001 par value 3,402 N/A N/A
Sale
Common Stock, $0.001 par value 18,828 $3.69 $69,475
Sale
Common Stock, $0.001 par value 23,291 N/A N/A
Sale
Common Stock, $0.001 par value 5,000 N/A N/A
Sale
Common Stock, $0.001 par value 5,018 N/A N/A
Sale
Common Stock, $0.001 par value 10,000 $4.31 $43,100
Sale
Common Stock, $0.001 par value 76,283 $1.9 $145,243
Sale
Common Stock, $0.001 par value 1,125 $3.06 $3,443
Sale
Common Stock, $0.001 par value 2,086 N/A N/A
Sale
Common Stock, $0.001 par value 938 N/A N/A
Sale
Common Stock, $0.001 par value 1,854 N/A N/A
Sale
Common Stock, $0.001 par value 2,500 N/A N/A
Sale
Common Stock, $0.001 par value 5,085 N/A N/A
Sale
Common Stock, $0.001 par value 5,000 N/A N/A
Sale
Common Stock, $0.001 par value 11,381 N/A N/A
Sale
Common Stock, $0.001 par value 2,388 N/A N/A
Sale
Common Stock, $0.001 par value 16,493 N/A N/A
Sale
Common Stock, $0.001 par value 1,882 N/A N/A
Sale
Common Stock, $0.001 par value 2,285 N/A N/A
Sale
Common Stock, $0.001 par value 10,499 N/A N/A
Sale
Common Stock, $0.001 par value 235 N/A N/A
Sale
Common Stock, $0.001 par value 3,290 N/A N/A
Sale
Common Stock, $0.001 par value 1,840 N/A N/A
Sale
Common Stock, $0.001 par value 3,900 N/A N/A
Sale
Common Stock, $0.001 par value 1,948 N/A N/A
Sale
Common Stock, $0.001 par value 220 N/A N/A

Spectrum Pharmaceuticals key executives

Spectrum Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: